The main elements which define the variability in the TME includes but are not limited to genomic instability, tumor type, tumor location, presence of mutations such as KRAS, EGFR, PTEN etc., presence of lymph nodes, adipose tissue in the vicinity, and therapeutic interventions [32]. The gene discussed is EGFR; the disease is neoplasm.